Craig-Hallum analyst Matt Hewitt initiated coverage of Clover Health (CLOV) with a Buy rating and $6 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on CLOV: Clover Health price target raised to $4.20 from $3.20 at Canaccord Clover Health Reports Strong Financial Growth in Q3 2024 Clover Health reports Q3 EPS (2c), consensus (4c) Clover Health options imply 13.9% move in share price post-earnings